Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
AIMS/HYPOTHESIS: Sulfonylureas are widely prescribed glucose-lowering medications for diabetes, but the extent to which they improve glycaemia is poorly documented. This systematic review evaluates how sulfonylurea treatment affects glycaemic control. METHODS: Medline, EMBASE, the Cochrane Library...
Asıl Yazarlar: | Hirst, J, Farmer, A, Dyar, A, Lung, T, Stevens, R |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Springer-Verlag
2013
|
Benzer Materyaller
-
Estimating the effect of sulfonylurea on HbA in diabetes: A systematic review and meta-analysis
Yazar:: Hirst, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Efficacy of sulfonylurea treatment for glycaemic control in diabetes: a systematic review and meta-analysis
Yazar:: Farmer, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012) -
Use of HbA1c in the diagnosis of diabetes.
Yazar:: Farmer, A
Baskı/Yayın Bilgisi: (2012) -
Timings for HbA1c testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data
Yazar:: Hirst, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change
Yazar:: Hirst, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)